President Softgel & Oral Tech of Catalent, Inc. (NYSE:CTLT), Gennadios Aristippos, sells 13,662 shares worth $1,405,044
According to Catalent, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 07:19 AM, company President Softgel & Oral Tech, Gennadios Aristippos disclosed selling 13,662 shares at a cost of $102.84. At the time of this transaction (Dec 21), this trade was worth $1,405,044 in total. As of Dec 21, Gennadios Aristippos now owns 51,425 shares in total worth about $5,393,968.25.
For the last few recent trades made by Catalent, Inc. (NYSE:CTLT) President Softgel & Oral Tech, Gennadios Aristippos, we have the following information:
- SEC Form 4 filing: Jun 25: Sold 8,325 shares at the rate of $73.00 per share. Total worth of this trade was $607,725. Total number of shares owned as of Jun 25 were 44,520
- SEC Form 4 filing: Nov 25: Sold 45,256 shares at the rate of $52.55 per share. Total worth of this trade was $2,378,203. Total number of shares owned as of Nov 25 were 44,241
- SEC Form 4 filing: Mar 21: Sold 3,392 shares at the rate of $42.18 per share. Total worth of this trade was $143,089. Total number of shares owned as of Mar 21 were 34,726
Posted by
George Daniels
on Wednesday December 23 2020, 9:28 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
